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fatigue measured by one subscale of the FSMC correlated 
most significantly with mental speed, working memory, and 
verbal short-term memory, while the motor subscale was as-
sociated with upper and lower extremity functions, mental 
speed, visual short-term memory, and working memory. A 
differentiation between lesion localization and fatigue se-
verity in the motor or cognitive domain was only possible 
when applying the FSMC. Patients with cortical lesions 
scored higher on the cognitive subscale, while patients with 
subcortical lesions showed higher physical subscale scores. 
 Conclusion: The present pilot study revealed differences be-
tween lesion localization and subdomains of fatigue after 
stroke by applying a new fatigue scale (FSMC). The results 
underline the necessity for separate assessment of motor 
and cognitive fatigue in stroke patients. 
 Copyright © 2012 S. Karger AG, Basel 
 Introduction 
 Post-stroke fatigue (PSF) prevalence varies between 30 
and 72%  [1–3] and affects more women  [2, 4, 5] . PSF 
seems to be a very long-lasting symptom. Over 1 year af-
ter stroke half of the patients still experience fatigue  [6] , 
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 Abstract 
 Background/Aims: Post-stroke fatigue (PSF) is an important 
but still controversial issue since knowledge on its nature is 
still humble. The aim of the present study was to characterize 
PSF beyond the subacute phase.  Methods: Thirty-one stroke 
patients (gender: 6 female, 25 male; age range: 35–76 years; 
28 patients with ischemic stroke, 3 patients with hemorrhag-
ic stroke; mean delay after stroke: 50.65  8 31.57 days) were 
recruited and assessed by measures of fatigue (Fatigue Scale 
for Motor and Cognitive Functions [FSMC], Fatigue Severity 
Scale, and Modified Fatigue Impact Scale), depression (Beck 
Depression Inventory Fast Screen), cognition (Brief Repeat-
able Battery of Neuropsychological Tests) and upper and 
lower extremity functions (Nine-Hole Peg Test and 25-foot 
walk).  Results: Depending on the different scales, PSF preva-
lence ranged from 16.1 to 58.1%. Depression measures cor-
related significantly ( r (29)  6 0.46; p  ! 0.01) with the results 
of all fatigue scales. Seventy-one percent of patients showed 
cognitive deficits in at least one cognitive domain. Cognitive 
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whereas other symptoms improve much faster during the 
rehabilitation process. In addition, 40–50% of stroke pa-
tients report that fatigue is their main complaint or one 
of their most debilitating symptoms  [6, 7] .
 Unfortunately, today there is still relatively limited 
knowledge on the pathophysiology of PSF and the rela-
tion to comorbidities, such as depression and cognitive 
deficits  [8] . Although PSF is of a subjective nature, for its 
mental as well as for its physical components, studies 
published so far focused only on the physical compo-
nents, mostly neglecting the cognitive part. A more elab-
orated differentiation of the lesion sites might help to 
learn more about the pathological mechanisms respon-
sible for the different clinical characteristics. While some 
studies could not find any relation between lesion site and 
PSF  [7, 9] , Staub and Bogousslavsky  [10] , based on a pilot 
study, proposed a cortico-subcortical gradient in fre-
quency to develop fatigue from low frequency in cortical 
lesions to a higher frequency in patients with subcortical 
and brainstem lesions. This assumption was substanti-
ated by a recent study from Tang et al.  [11] , who found 
more basal ganglia infarcts in patients with fatigue than 
in non-fatigued individuals.
 Fatigue is often considered as a symptom of post-
stroke depression (PSD), an assumption that is supported 
by the evidence of significant correlations between scores 
of fatigue severity and depression  [4, 12–15] . However, 
findings of other studies suggest that PSF and PSD might 
be independent entities since PSF can occur in stroke pa-
tients without any signs of depression  [7, 15] .
 Taken together, little knowledge is still available on the 
nature of PSF and related aspects. This might not only be 
due to the unknown pathophysiological processes but 
also due to the psychometric properties of the applied fa-
tigue instruments so far. Since fatigue is a purely subjec-
tive symptom and since objective measures to quantify 
and diagnose are missing, a reliable assessment depends 
on psychometric measures (fatigue questionnaires). The 
problem of many existing fatigue scales, however, is that 
they have methodological limitations which are related to 
scale construction and validation. Thus, the aim of the 
present pilot study was to characterize fatigue over the 
subacute phase of stroke by three different fatigue instru-
ments, the Fatigue Severity Scale (FSS)  [16] , the Modified 
Fatigue Impact Scale (MFIS)  [17] , and the Fatigue Scale 
for Motor and Cognitive Functions (FSMC)  [18] , a new 
fatigue instrument dedicated to a differentiation between 
cognitive and motor fatigue, and to relate our fatigue 
findings to measures of depression and cognitive perfor-
mance.
 Methods 
 Participants 
 Between 2007 and 2008, 31 stroke patients (6 women and 25 
men) with stroke were recruited from eight rehabilitation cen-
ters (Kantonsspital Bruderholz, RehaClinic Braunwald, Neurol-
ogische Klinik Elzach, Berner Klinik Montana, Reha-Klinik 
Walenstadtberg, Klinik Valens, Rheinburgklinik, and Kliniken 
Schmieder Allensbach) in Switzerland and Germany. Patients 
were between 35 and 76 (59.29  8 10.30) years old. Only patients 
without any other neurological or psychiatric diseases, as re-
vealed in medical records and actual anamnesis, were included. 
Additional exclusion criteria were clinical apparent aphasia and 
neglect to ensure full answers’ validity to questionnaires. Twen-
ty-eight patients suffered from ischemia and 3 from hemor-
rhage. Patient characteristics with respect to age, gender, educa-
tional level, stroke event, and stroke localization are shown in 
 table 1 . All subjects gave written informed consent. The study 
was approved by the local ethics committee of the University of 
Basel.
 Fatigue Assessment and Neuropsychological Examination 
 Neuropsychological examination was performed on average 
50.65  8  31.57 days after stroke by the Brief Repeatable Battery of 
Neuropsychological Tests (BRB-N)  [19] composed of tests of ver-
bal and visual short- and long-term memory, information pro-
cessing speed, working memory, and executive functions. Upper 
and lower extremity functions were assessed by the Nine-Hole 
Peg test (9-HPT) and the 25-foot walk measure  [20] , respectively. 
For each patient, the whole assessment procedure took 2 h. For 
statistical comparisons, z values for all tests were calculated  [21, 
22] . In contrast to Scherer et al.  [21] , BRB-N z values lower than 
–1.65 were rated as cognitively impaired since this cutoff repre-
sents the 90% confidence interval.
 Fatigue was assessed by two well-known instruments, the FSS 
 [16] and the MFIS  [17] , as well as by a recently developed scale, the 
FSMC  [18] . The psychometric properties of the FSMC are excel-
lent with Cronbach’s   , as a measure for internal consistency, of 
0.95 for the total scale, 0.93 for the cognitive subscale, and 0.91 for 
the motor subscale. In a large validation study, the scale was eval-
uated on 309 multiple sclerosis patients and 147 healthy controls. 
In a direct comparison with the FSS and MFIS, a ROC analysis 
revealed that sensitivity and specificity were highest for the 
FSMC.
 Twenty-four patients (4 women and 20 men) accepted to par-
ticipate in a retest for fatigue assessment after 4 weeks. All patients 
were back at home at this time. This information was used to as-
sess stability of PSF symptoms.
 Depression was assessed by the Beck Depression Inventory 
(BDI)  [23] . To avoid somatic interdependency between stroke, de-
pression, and fatigue we excluded all somatic items in accordance 
to the BDI-Fast Screen for further analysis (BDI-FS  [24] ). Further, 
information on stroke event was based upon visual inspection of 
actual MRI scans of the individual patient. Stroke classification 
of affected territories comprised a cortical/subcortical subdivi-
sion.
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 Results 
 Assessment of Fatigue 
 When applying the FSS, 5 patients (16.1%) were above 
the critical cutoff of 4.6 for fatigue  [25] , whereas when us-
ing the MFIS, 11 patients (35.5%) reached clinically rele-
vant values. However, when applying the FSMC, 58.1% of 
patients turned out to have clinically relevant fatigue 
symptoms of different severity grades. Detailed informa-
tion on fatigue prevalence and severity measured with the 
FSMC is given in  table 2 .
 In the 24 patients who participated in the retesting 4 
weeks later, fatigue scores measured with the FSS and the 
MFIS remained stable. In contrast, when fatigue was 
measured with the FSMC, fatigue symptoms obviously 
worsened over time. Patients showed significantly in-
creased scores after 4 weeks on both subscales as well as 
an increased FSMC total score (see  table 3 for details).
 Relation between Depression and Fatigue 
 Mean depression score on BDI-FS was 1.94  8 2.32. 
Twenty-five patients (81%) showed no signs of depressive 
symptoms, 5 patients (16%) were classified with mild de-
pressive symptoms, and only 1 patient (3%) scored in the 
range of severe depression. The BDI-FS score correlated 
significantly with the FSS score ( r (29) = 0.46, p = 0.009), 
the MFIS score ( r (29) = 0.62, p  ! 0.001), as well as all sub-
scores of the FSMC (cognitive:  r (29) = 0.61, p  ! 0.001; mo-
tor: r (29) = 0.54, p = 0.002; sum score:  r (29) = 0.61, p  ! 
0.001).
 Stroke Localization and Fatigue 
 Six patients had cortical lesions, 19 suffered from sub-
cortical lesions, and 6 patients had mixed subcortical and 
cortical lesions. In  figure 1 , mean values of the fatigue 
subscales for the three lesion localization groups are dia-
grammed. In the cognitive subscale of the FSMC, patients 
Table 1. Patient characteristics
Mean SD
Age, years 59.29 10.30
n %
Gender
Female 6 19
Male 25 81
Educational level
Secondary school 5 16
College 20 65
University 6 19
Stroke event
First 23 74
Second 4 13
Third 2 7
Stroke type
Ischemia 28 90
Intracerebral hemorrhage 3 10
Stroke localization
Cortical 6 19
Left hemisphere 1 3
Right hemisphere 4 13
Both hemispheres 1 3
Subcortical 19 62
Left hemisphere 7 23
Right hemisphere 8 26
Both hemispheres 2 6
Unknown 2 6
Cortical and subcortical 6 19
Left hemisphere 3 10
Right hemisphere 3 10
Both hemispheres 0 0
Table 2. F atigue prevalence and severity measured with the FSMC
FSMC-C
(n = 31)
FSMC-M
(n = 31)
FSMC-S
( n = 31)
n % n % n % 
No fatigue 15 48.4 12 38.7 13 41.9
Mild fatigue 7 22.6 6 19.4 6 19.4
Moderate fatigue 5 16.1 5 16.1 7 22.6
Severe fatigue 4 12.9 8 25.8 5 16.1
FSM C-C = Cognitive subscale; FSMC-M = motor subscale; 
FSMC-S = sum score of scale.
Table 3. F atigue scores measured at baseline and after 4 weeks
Baseline A fter 4 weeks
Mean SD Mean SD t p
FSS 3.00 0.32 3.73 0.39 –1.81 0.083
MFIS 26.79 3.86 32.21 4.27 –1.18 0.252
FSMC-C 19.63 1.61 24.92 2.12 –2.40 0.025
FSMC-M 22.67 1.74 28.00 2.21 –2.22 0.037
FSMC-S 42.29 3.06 52.92 4.18 –2.34 0.028
FSM C-C = Cognitive subscale; FSMC-M = motor subscale; 
FSMC-S = sum score of scale.
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with cortical lesions reached the highest values, while pa-
tients with subcortically located lesions reached the low-
est. In the physical subscale of the FSMC this effect 
changed: patients with cortical lesions showed less fa-
tigue symptoms than patients with subcortical lesions. 
Patients with mixed lesions showed values between the 
other two groups. The FSMC total score did not differ 
between the three groups (not diagrammed). This asso-
ciation between lesion localization and differentiated fa-
tigue symptoms could not be detected by using the sub-
scales of MFIS. Here, patients with subcortically located 
lesions always reached the highest fatigue values (see  ta-
ble 4 for further information).
 In  table 4 , means and SD of the FSMC and MFIS scores 
for the three lesion localization subgroups are displayed. 
Due to the small number of patients, Cohen’s  d  [26] for 
effect sizes of group differences between patients with 
cortical and subcortical lesions was calculated. For this 
purpose, the mean differences of scores between patients 
with cortically and patients with subcortically located le-
sions were divided by the pooled SD
	 
 	 
2 2 .1 1
2
cortical subcortical
cortical cortical subcortical subcortical
cortical subcortical
M M
d
SD n SD n
n n

  
 
 
 To evaluate the effect sizes,  d = 0.20 was rated as a 
small effect,  d = 0.50 as a moderate effect, and  d = 0.80 as 
a large effect. By applying this statistical procedure, small 
effect sizes were found for the differences in FSMC scores 
between cortically and subcortically located lesions on 
both subdomains of the FSMC, whereas the sum score 
did not differ in both of these groups of patients (see  ta-
ble 4 for more details). 
 Relation between Cognition, Upper and Lower 
Extremity Functions and Fatigue 
 Twenty-two patients (71%) showed reduced perfor-
mance in one or more cognitive subtests of the BRB-N. 
Most deficits were observed in executive functions fol-
lowed by mental speed, verbal memory, and working 
memory. Sixty-one percent of patients showed clinically 
relevant upper extremity, and 10% lower extremity dys-
functions.  Table 5 shows means and SD for the cognitive 
performance and the percentage of patients having clini-
cally meaningful deficits on each cognitive domain and 
upper and lower extremity functions.
 To assess relations between fatigue and cognitive func-
tioning, bivariate correlations were calculated. As shown 
in  table 6 , FSS scores neither correlated significantly with 
any cognitive measures nor with those of upper and low-
er extremity functions. The cognitive subscale of the 
MFIS correlated with verbal short-term memory, mental 
speed, and executive functions, while the physical sub-
scale was only related to mental speed but not to motor 
functions. The cognitive subscale of the FSMC was re-
lated to verbal short-term memory, mental speed, and 
working memory, while the motor subscale was related to 
cognitive domains, such as visual short-term memory, 
mental speed, and working memory, but also to upper 
and lower extremity functions, measured with the 9-HPT 
and 25-foot walk (see  table 6 for details).
 Sensitivity and Specificity of the Different Fatigue 
Scales 
 A logistic regression analysis was computed for the 
three applied fatigue instruments to evaluate sensitivity 
and specificity of the scales. For this purpose, 31 age-
matched healthy controls from our large database on the 
FSMC and the 31 stroke patients were included in the lo-
gistic regression. Hereby, the percentage of patients cor-
rectly diagnosed as stroke patients (‘sensitivity’) and the 
percentage of controls correctly classified as not having 
stroke (‘specificity’) could be determined. Thus, specific-
ity and sensitivity were analyzed with respect to ‘stroke 
diagnosis’. Since PSF is a well-known symptom in stroke 
patients that by definition should not be present in healthy 
subjects, the terms ‘sensitivity and specificity’ refer to the 
ability of the different scales to relate fatigue to the un-
derlying diagnosis of stroke. The FSS reached the lowest 
values (sensitivity: 51.6%; specificity: 61.3%), while the 
0
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FSMC-C FSCM-M
30
Cortical lesions
Subcortical lesions
Cortical and
subcortical lesions
 Fig. 1. Mean scores for FSMC-C (subscale for cognitive fatigue) 
and FSMC-M (subscale for physical fatigue) for all three types of 
lesions. 
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MFIS (sensitivity: 67.7%; specificity: 71.0%) and the 
FSMC (sensitivity: 64.5%; specificity: 71.0%) reached 
comparable values.
 Discussion 
 Fatigue Prevalence and Depression 
 A comparison between FSMC and two other well-
established fatigue scales (FSS and MFIS) revealed that 
fatigue prevalence rates were highest (58.1%) when the 
FSMC was applied. Obviously, the graduation system of 
the FSMC with cutoff values for mild, moderate, and 
severe fatigue offers a more accurate evaluation of the 
mild fatigue symptoms than the overall cutoff of the 
MFIS.
 Test-retest results of the FSMC revealed an increase in 
fatigue severity. PSF worsening within 4 weeks can be ex-
plained by cognitive processes of realizing that one is not 
yet back to normal and that recovery takes much longer 
than expected. In a study by Christensen et al.  [27] , slight 
improvement of fatigue symptoms was described after 3 
months, supporting the idea that reduction of PSF symp-
toms needs time.
 In the present study, significant correlations between 
PSF and PSD were found. However, the majority of pa-
tients did not show clinically relevant PSD, although 
 1 58% were diagnosed as having PSF. In contrast to previ-
ous studies, in our study, we applied the BDI-FS where the 
physical items related to depression are excluded. Thus, 
the lower amount of patients being diagnosed with PSD 
can in part be due to this issue. Of much more interest is 
the finding that, obviously, PSF can occur in patients 
Table 4. M ean FSMC and MFIS scores for the three lesion localization groups
Cortical and sub-
cortical localization
Cortical
localization
Subcortical
l ocalization
d
Mean SD Mean SD Mean SD
FSMC-C 22.50 4.81 23.17 11.07 21.05 9.81 0.21
FSMC-M 23.33 4.97 23.33 11.62 25.74 9.92 –0.23
FSMC-S 45.83 9.11 46.50 22.56 46.79 18.42 –0.01
MFIS-C 14.83 9.06 9.33 10.25 16.37 9.26 –0.74
MFIS-M 14.50 10.29 9.83 9.45 11.68 9.89 –0.19
MFIS-S 32.33 19.67 21.00 21.28 31.63 19.46 –0.53
FSM C-C = Cognitive subscale; FSMC-M = motor subscale; FSMC-S = sum score of scale; MFIS-C = cogni-
tive subscale; MFIS-M = motor subscale; MFIS-S = sum score.
Table 5. C ognitive performance and upper and lower extremity 
functions
Mean SD Clinically
relevant
values, %
Verbal short-term memory
SRT-LTS –0.41 1.52 23
SRT-CLTR –0.36 1.27 16
Verbal long-term memory
SRT-DR –1.10 1.80 39
Visual short-term memory
10/36 Spatial Recall Test 0.24 1.15 3
Visual long-term memory
10/36-DRd 0.16 1.30 10
Mental speed
SDMT –1.14 1.46 36
Executive functions
Word list generation –1.39 0.87 42
Working memory
PASAT –1.11 1.33 26
Upper extremity
9-HPT –1.30 1.09 61
Lower extremity
25-foot walka 0.22 0.31 10
S RT-LTS = Selective Reminding Test – Long-Term Storage; 
SRT-CLTR = Selective Reminding Test – Consistent Long-Term 
Retrieval; SRT-DR = Selective Reminding Test –  Delayed Recall; 
10/36-DR = Spatial Recall Test – Delayed Recall; SDMT = Symbol 
Digits Modalities Test; PASAT = Paced Auditory Serial Addition 
Test (n = 26). a n = 28.
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without showing any signs of depression. Further,  figure 
2 illustrates that the opposite relation seems to be less 
likely, leading to the hypothesis that PSD might be re-
garded as a feature of PSF. Thus, in summary, these re-
sults clearly demonstrate the necessity to assess the two 
symptoms reliably to provide the right diagnosis and 
therapeutic approach to the patients.
 Lesion Localization and Fatigue 
 Regarding the question to which extent the localiza-
tion of the lesion influences the occurrence of fatigue, we 
found that patients with subcortical lesions showed high-
er MFIS scores on all subscales compared to patients with 
cortical lesions. This result is in accordance with the the-
ory proposed by Staub and Bogousslavsky  [10] . Contrari-
ly, the results of the FSMC revealed another more differ-
entiated picture that was not detectable by the MFIS: pa-
tients with subcortical lesions showed higher scores on 
motor fatigue, while cognitive fatigue was more frequent 
in patients with cortical lesions. The small but relevant 
effect sizes for the differences in fatigue scores between 
subcortical and cortical lesions elucidate the necessity of 
Table 6. C orrelations between fatigue and cognitive function, and upper and lower extremity functions
FSS MFIS-C MFIS-M MFIS-S FSMC-C FSMC-M FSMC-S
Verbal short-term memory
SRT-LTS –0.18 –0.38 * –0.29 –0.36* –0.39* –0.36 –0.35
SRT-CLTR –0.16 –0.38 * –0.34 –0.39* –0.36* –0.22 –0.31
Verbal long-term memory
SRT-DR –0.28 –0.33 –0.22 –0.30 –0.34 –0.17 –0.27
Visual short-term memory
10/36 Spatial Recall Test –0.08 –0.05 –0.22 –0.14 –0.26 –0.39* –0.34
Visual long-term memory
10/36-DR –0.18 –0.08 –0.22 –0.14 –0.26 –0.34 –0.32
Mental speed
SDMT –0.23 –0.45* –0.39* –0.44* –0.54** –0.43* –0.52**
Executive functions
Word list generation –0.14 –0.41* –0.31 –0.41* –0.33 –0.05 –0.20
Working memory
PASAT –0.21 –0.25 –0.08 –0.17 –0.49* –0.44* –0.50**
Upper extremity
9-HPT 0.02 0.13 0.04 0.23 –0.12 –0.40* –0.28
Lower extremity
25-foot walka –0.37 –0.14 –0.18 –0.15 –0.35 –0.43* –0.41*
M FIS-C = Cognitive subscale; MFIS-M = motor subscale; MFIS-S = sum score of scale; FSMC-C = cognitive subscale; FSMC-M = 
motor subscale; FSMC-S = sum score of scale; SRT-LTS = Selective Reminding Test – Long-Term Storage; SRT-CLTR = Selective 
Reminding Test – Consistent Long-Term Retrieval; SRT-DR = Selective Reminding Test – Delayed Recall; 10/36-DR = Spatial Recall 
Test – Delayed Recall; SDMT = Symbol Digits Modalities Test; PASAT = Paced Auditory Serial Addition Test (n = 26). a n = 28.
* p < 0.05; ** p < 0.01.
0
0
BD
I-
FS
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
20.00 40.00
FSMC sum score
60.00 80.00 100.00
10.00
 Fig. 2. Values of each patient for depression (BDI-FS) and fatigue 
(FSMC sum score). While there are no patients showing signs of 
depression independently of fatigue, the opposite relation was de-
tected: patients with fatigue, in most of the cases, also show signs 
of depression. 
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a differentiation between cognitive and motor fatigue to 
better understand the pathophysiology of PSF. This result 
is of importance insofar as it underlines for the first time 
in a sample of stroke patients that cognitive and motor 
fatigue are probably different pathophysiological entities 
where cognitive fatigue can be assumed to be of cortical 
and motor fatigue of subcortical origin.
 Other studies, however, could not find any significant 
relation between stroke localization and fatigue  [5, 14, 
28] . This might primarily be due to the applied fatigue 
instruments which either did not differentiate between 
motor and cognitive fatigue or were less sensitive than the 
applied FSMC. These differences, due to the sensitivity of 
the fatigue scales, are also reflected in our study when 
comparing FSMC to MFIS results.
 Cognition, Upper and Lower Extremity Functions, 
and Fatigue 
 Seventy-one percent of subjects showed cognitive im-
pairment mainly in the domains of executive functions, 
mental speed, and memory. Using FSS and MFIS for as-
sessing fatigue, none or only a few correlations, respec-
tively, were found between fatigue level and cognitive 
performance. However, when the FSMC was applied, 
cognitive fatigue turned out to be significantly related to 
the performance in several cognitive domains, whereas 
physical fatigue was mainly related to upper and lower 
extremity functions but additionally also to cognitive 
measures assessing speed and stamina. It may be intui-
tively right that cognitive fatigue is mainly reflected by 
neuropsychological outcomes and motor fatigue mainly 
by physical functioning. However, it has to be noted that 
these correlations are barely seen in patients with multi-
ple sclerosis  [16] . In the present study, cognitive fatigue 
seems to be mainly associated with cognitive function-
ing, while motor fatigue is not exclusively related to phys-
ical functioning but also to cognitive aspects, such as 
speed and stamina. As already reported for lesion local-
ization, the association between motor and cognitive 
functions and cognitive and motor fatigue was only found 
when using the FSMC. The cognitive and physical sub-
scales of the MFIS were not able to show the above-men-
tioned discrimination, although sensitivity and specific-
ity values were comparable to the FSMC.
 Study Limitations 
 Our study has several limitations. First, the sample 
size was rather small, and subgroup statistics on the in-
teresting questions about stroke localization and occur-
rence and subtype of fatigue could only be performed by 
non-parametric analyses and differences could only be 
quantified by effect sizes. Since differences were still de-
tectable, these results encourage the performance of fu-
ture studies on larger samples. Second, the numbers of 
patients in the subgroups with respect to lesion localiza-
tion were not of equal size, thus making statistical com-
parisons difficult. Third, a more detailed classification of 
lesion localization would be warranted to better under-
stand the origin of PSF. Fourth, 3 patients did not suffer 
from ischemia but had intracerebral hemorrhage. This 
might have an influence on cognitive performance, time 
of recovery after stroke event, and fatigue. Our sample, 
however, was too small to run meaningful subgroup sta-
tistics with respect to stroke type. Nevertheless, leaving 
out the 3 hemorrhagic patients would not have changed 
the pattern of results entirely. Fifth, more detailed lesion 
characteristics and more elaborated clinical data were not 
available, since the focus of our study was more on the 
methodological issues related to the new scale than on the 
characterization of the clinical population. This will be a 
further issue in future studies.
 Despite these limitations, the present pilot study for 
the first time revealed differences between lesion local-
ization and subdomains of fatigue after stroke by apply-
ing a new fatigue scale. So far, the results might be con-
clusive enough to change behavior in clinical practice to-
wards separate assessment of motor and cognitive fatigue 
in patients after stroke.
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